Pfizer bought Global Blood Therapeutics Global Blood Therapeutics from 10/5/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Pfizer completed its acquisition of Global Blood Therapeutics for $5.4, or $68.5 per share.

Global Blood Therapeutics

Review

Source:

{source} pictogram

investors.pfizer.com

Vladimir Petenev

News editor

Write your comment first

News feed

Yandex.Taxi launched an electric cab service in the Kaliningrad region

3/15/24 YNDX

Gazprom Neft reports for 2023 by IFRS

3/14/24 SIBN

Board of Directors of ITC recommended dividends for 2023

3/14/24 WTCM

European Electrotechnics will become part of OMZ Perspective Technologies Group

3/14/24 EELT

Cherkizovo shipped a large shipment of soybean oil to China

3/14/24 GCHE

X5 Retail Group launches 5Post.Market online store

3/14/24 X5

TCS Holding will present its long-term strategy by the end of the year

3/14/24 T

Shareholders of Diasoft approved dividends for 2023

3/14/24 DIAS

Fesco delivered the first shipment of bananas from India to Russia

3/14/24 FESH

TCS Holding launches buyback program

3/14/24 T